Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

ClinicalTrials.gov ID: NCT05382208

Public ClinicalTrials.gov record NCT05382208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05382208
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Weill Medical College of Cornell University
Other
Enrollment
133 participants

Conditions and interventions

Interventions

  • Doxycycline Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 21, 2022
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027
Last update posted
Jan 25, 2026

2022 – 2027

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
University of California Los Angeles Los Angeles California 90095
University of California San Diego San Diego California 92103
Miami University Miami Florida 33136
Emory University Atlanta Georgia 30329
Tulane University New Orleans Louisiana 70112
Johns Hopkins University School of Medicine Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
Washington University School of Medicine St Louis Missouri 63110
SUNY Downstate Medical School Brooklyn New York 11203
Weill Cornell Medicine New York New York 10065
University of North Carolina Chapel Hill North Carolina 27514
Duke University School of Medicine Durham North Carolina 27704
University of Cincinnati College of Medicine Cincinnati Ohio 45267
Case Western University Cleveland Ohio 44106
Ohio State University Columbus Ohio 43210
Temple University Philadelphia Pennsylvania 19140
University of Pittsburgh Pittsburgh Pennsylvania 15261
University of Texas, McGovern Medical School Houston Texas 77030
University of Washington Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05382208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05382208 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →